The pathogens considered most dangerous to human health included Aspergillus fumigatus, which comes from mold and infects the ...

Without immediate action, humanity will face a potentially disastrous escalation in resistance in fungal disease, a renowned ...

F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments for infections ...

Crystal Flush’s Super-40 Probiotic, a blend of six potent strains totaling 40 billion CFUs, enhances gut health and aims to ...

F2G submitted its initial approval application with data from the first 100 patients enrolled in a phase 2b study of the drug ...

A group of scientists at the Department of Energy's Oak Ridge National Laboratory have conducted neutron scattering research ...

Kerassentials is a novel formula designed to combat antifungal resistance and alleviate toenail itching. The formula h ...

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a renowned group ...

The drug is being developed to treat invasive fungal infections including aspergillosis - a rare infection that is resistant to antifungal medication. The U.S. Food and Drug Administration ...

Devastating health impacts Resistance is nowadays the rule rather than the exception for the four currently available antifungal classes, making it difficult - if not impossible – to treat many ...

Olorofim is licensed in Europe and Asia to Japanese pharma Shionogi, which paid $100 million upfront for rights to the drug ...

Basilea Pharmaceutica has entered into a multi-year agreement with the Biomedical Advanced Research and Development Authority ...